Literature DB >> 6659876

Functional and morphological abnormalities induced by ouabain intoxication of the rabbit retina.

F Norido, R Canella, A Gorio.   

Abstract

Several researchers have recently used an intravitreal ouabain injection to induce a suitable model of experimental retinopathy and optic neuropathy in various animals. Ouabain administration into the vitreous body of rabbit causes an irreversible degeneration of the retinal layers and consequently of the optic nerve. The degeneration is proportional to the amount of injected drug. Electroretinographic recordings (ERG) show that these structural abnormalities are related to an inhibition of the electric retinal activity as the dose-dependent reduction of ERG waves amplitude has shown. Moreover, ERG and visual evoked responses (VER) measured at the same time evidence that the intravitreal injection of 1.7 nmol ouabain may block the impulse conduction along the optic nerve. This can be proved by the fact that 90 min after an ouabain injection VER disappears, while ERG is only partially reduced. These results are correlated with both morphological observation and autoradiographic studies on 3H-ouabain distribution in different retinal layers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6659876     DOI: 10.1007/BF00684918

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  Time- and dose-dependent influence of ouabain on the ultrastructure of optic neurones.

Authors:  H Wolburg
Journal:  Cell Tissue Res       Date:  1975-12-18       Impact factor: 5.249

2.  STUDIES ON SODIUM-POTASSIUM-ACTIVATED ADENOSINE TRIPHOSPHATASE. X. OCCURRENCE IN RETINAL RODS AND RELATION TO RHODOPSIN.

Authors:  S L BONTING; L L CARAVAGGIO; M R CANADY
Journal:  Exp Eye Res       Date:  1964-03       Impact factor: 3.467

3.  A COMPARISON OF DIGITALIS INTOXICATION IN TWO SEPARATE PERIODS.

Authors:  M H DUBNOW; H B BURCHELL
Journal:  Ann Intern Med       Date:  1965-05       Impact factor: 25.391

4.  PI-5 SPECIFICITY IN DIGITOXIN TOXICITY: A CASE REPORT.

Authors:  H C GIBSON; D M SMITH; M ALPERN
Journal:  Arch Ophthalmol       Date:  1965-08

5.  Influence of ouabain on the fine structure of teleost retina.

Authors:  H Wolburg
Journal:  Acta Neuropathol       Date:  1976-03-30       Impact factor: 17.088

6.  Effects of alpha-adrenergic blockers on visual evoked responses in rabbits.

Authors:  H C Sabelli; F Bartizal; W J Giardina; S B Myles
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-09

7.  Energy metabolism of the microscopic structures of the cochlea, the retina, and the cerebellum.

Authors:  F M Matschinsky
Journal:  Adv Biochem Psychopharmacol       Date:  1970

8.  [Retinal poisoning by digitalis].

Authors:  J Babel; N Stangos
Journal:  Bull Soc Belge Ophtalmol       Date:  1972

9.  Ocular manifestations of digitalis toxicity. Discussion and report of three cases of central scotomas.

Authors:  D M Robertson; R W Hollenhorst; J A Callahan
Journal:  Arch Ophthalmol       Date:  1966-11

10.  Ocular distribution of digoxin-3H in the cat.

Authors:  M W Lufkin; C E Harrison; J W Henderson; K N Ogle
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

View more
  3 in total

1.  Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury.

Authors:  Bruce A Berkowitz; Robin Roberts; Hongmei Luan; David Bissig; Bang V Bui; Marius Gradianu; David J Calkins; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

2.  Monosialoganglioside (GM1) treatment of ouabain-induced retinopathy in the rabbit.

Authors:  F Norido; R Canella; R Zanoni; A Gorio
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  Ouabain inhibition of Na/K-ATPase across the retina prevents signed refractive compensation to lens-induced defocus, but not default ocular growth in young chicks.

Authors:  Melanie J Murphy; Sheila Gillard Crewther
Journal:  F1000Res       Date:  2013-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.